DMAAR

Drugs Made In America Acquisition Corp. rights are derivative securities that give holders the right to receive additional securities upon the completion of the SPAC's business combination. Rights typically allow holders to purchase fractional shares or warrants of the post-merger entity at predetermined terms. These instruments are distributed to early investors and trade separately from common shares. Investors should review the SPAC's prospectus and rights agreement for specific terms, conversion ratios, and expiration conditions.